DOI QR코드

DOI QR Code

Characterization of Constitutively Activating Eel Follicle-Stimulating Hormone Receptor

  • Kim, Jeong-Soo (Animal Biotechnology, Graduate School of Future Convergence Technology, Hankyong National University) ;
  • Byambaragchaa, Munkhzaya (Animal Biotechnology, Graduate School of Future Convergence Technology, Hankyong National University) ;
  • Min, Kwan-Sik (Animal Biotechnology, Graduate School of Future Convergence Technology, Hankyong National University)
  • Received : 2019.09.23
  • Accepted : 2019.11.21
  • Published : 2019.12.31

Abstract

This study aimed to investigate the function of the constitutively activating mutation D540G on eel FSHR activity by in vitro functional studies. Site-directed mutagenesis was carried out to generate the D-to-G mutation at position 540 of the pcDNA3-eel FSHR construct. Vectors expressing either wild type or mutant receptor were transfected into Chinese hamster ovary (CHO-K1) cells. The functional characteristics of both the wild type and mutant receptors were analyzed by a cAMP assay. cAMP accumulation was highly increased in cells transfected with the D540G mutant receptor in a dose-dependent manner. Of note, basal cAMP levels were remarkably increased (~13.1-fold) with expression of this mutant when compared to wild type receptor. These findings suggest that the D540G mutation in the eel FSHR may contribute to ovulation during eel sex maturation as well as play a pivotal role in inducing FSHR activity.

Keywords

References

  1. Aittomaki K, Lucena JLD and Pakarinen P. 1995. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic hypogonadism. Cell. 82:959-968. https://doi.org/10.1016/0092-8674(95)90275-9
  2. Bae F, Pescovitz OH and Steinmetz R. 2009. No activating mutations of FSH receptor in four children with ovarian juvenile granulosa cells tumors and the association of these tumors with central precocious puberty. J Pediatr Adolesc Gyneco. 22:173-179. https://doi.org/10.1016/j.jpag.2008.10.003
  3. Beau I, Touraine P, Meduri G, Gougeon A, Desroches A, Matuchansky C, Milgrom E, Kuttenn F and Misrahi M. 1998. A novel phenotype related to partial loss of function mutations of the follicle stimulating hormone receptor. J Clin Invest. 102:1352-1359. https://doi.org/10.1172/JCI3795
  4. Bramble MS, Goldstein EH, Lipson A, Ngun T, Eskin A, Gosschalk JE, Roach L, Vashist N, Barseghyan H, Lee E, Arboleda VA, Vaiman D, Yuksel Z, Fellous M and Vilain E. 2016. A novel follicle-stimulating hormone receptor mutation causing primary ovarian failure: a fertility application of whole exome sequencing. Human Reproduction. 31:905-914. https://doi.org/10.1093/humrep/dew025
  5. Byambarachaa M, Kim DJ, Kang MH and Min KS. 2018a. Site specificity of eel luteinizing hormone N-linked oligosaccharides in signal transduction. Gen Comp Endocrinol. 268:50-56. https://doi.org/10.1016/j.ygcen.2018.07.015
  6. Byambarachaa M, Lee SY, Kim DJ, Kang MH and Min KS. 2018b. Signal transduction of eel luteinizing hormone receptor (eelLHR) and follicle stimulating hormone receptor (eelFSHR) by recombinant equine chorionic gonadotropin (rec-eCG) and native eCG. Dev Reprod. 22:55-63. https://doi.org/10.12717/DR.2018.22.1.055
  7. Fragoso MC, Latronico AC, Carvalho FM, Zerbini MC, Marcondes JA, Araujo LM, Lando VS, FrazzattoET, Mendonca BB and Villares SM. 1998. Activating mutation of the stimulatory G protein as a putative cause of ovarian and testicular human stromal Leydig cell tumors. J Clin Endocinol Metab. 83:2074-2078.
  8. Ghezelayagh Z, Totonchi M, Zarei-Moradi S, Asadpour O, Maroufizadeh S, Eftekhari-Yazdi E, Gourabi H and Mohseni-Meybodi A. 2016. The impact of genetic variation and gene expression of the follicle-stimulating hormone receptor on ovarian reserve. Cell J. 19:620-626.
  9. Gromoll J, Simoni M, Nordhoff V, Behre HM, De Geyter C and Nieschlag E. 1995. Functional and clinical consequences of mutations in the FSH receptor. Mol Cell Endocrinol. 125:177-182. https://doi.org/10.1016/S0303-7207(96)03949-4
  10. Gromoll J, Simoni M and Nieschlag E. 1996. An activating mutation of the follicle-stimulating hormone receptor autonomously sustains spematogenesis in a hypophysectomized man. J Clin Endocrinol Metab. 81:1367-1370. https://doi.org/10.1210/jcem.81.4.8636335
  11. Katari S, Wood-Trageser MA, Jiang H, Kalynchuk E, Muzumdar R, Yatsenko SA and Rajkovic A. 2015. Novel inactivating mutation of the FSH receptor in two siblings of indian origin with premature ovarian failure. J Clin Endocrinol Metab. 100:2154-2157. https://doi.org/10.1210/jc.2015-1401
  12. Kim DJ, Park CW, Byambaragchaa M, Kim SK, Lee BI, Hwang HK, Myeong JL, Hong SM, Kang MH and Min KS. 2016a. Data on the characterization of follicle-stimulating hormone monoclonal antibodies and localization in Japanese eel pituitary. Data Brief. 8:404-410. https://doi.org/10.1016/j.dib.2016.05.069
  13. Kim DJ, Park CW, Kim DW, Park HK, Byambaragchaa M, Lee NS, Hong SM, Seo MY, Kang MH and Min KS. 2016b. Production and characterization of monoclonal antibodies against recombinant tethered follicle-stimulating hormone from Japanese eel anguilla japonica. Gen Comp Endocrinol. 233:8-15. https://doi.org/10.1016/j.ygcen.2016.04.030
  14. Kim JM, Munkhuu O, Byambaragchaa M, Lee BI, Kim SK, Kang MH, Kim DH and Min KS. 2019. Site-specific roles of Nlinked oligosaccharides in recombinant eel follicle-stimulating hormone for secretion and signal transduction. Gen Comp Endocrinol. 276: 37-44. https://doi.org/10.1016/j.ygcen.2019.03.003
  15. Laue L, Chan WY, Hsueh A, Kudo M, Hsu SY and Wu SM. 1995. Genetic heterogeneity of constitutively activating mutations of the human luteinizing hormone receptor in familial male-limited precocious puberty. Proc Natl Acad Sci USA. 92:1906-1910. https://doi.org/10.1073/pnas.92.6.1906
  16. Layman LC and McDonough PG. 2000. Mutations of follicle stimulating hormone-${\beta}$ and its receptor in human and mouse: genotype/phenotype. Mol Cell Endocrinol. 161:9-17. https://doi.org/10.1016/S0303-7207(99)00217-8
  17. Lee SY, Byambaragchaa M, Kim JS, Seong HK, Kang MH and Min KS. 2017. Biochemical characterization of recombinant equine chorionic gonadotropin (rec-eCG), using CHO cells and pathHunter parental cells expressing equine luteinizing hormone/chorionic gonadotropin receptors (eLH/CGR). J Life Sci. 27:864-872. https://doi.org/10.5352/JLS.2017.27.8.864
  18. Liu H, Xu X, Han T, Yan L, Cheng L, Qin Y, Liu W, Zhao S and Chen Z. 2017. A novel homozygous mutation in the FSHR gene is causative for primary ovarian insufficiency. Fertility and Sterility. 108:1050-1055. https://doi.org/10.1016/j.fertnstert.2017.09.010
  19. Min KS, Hiyama T, Seong HH, Hattori N, Tanaka S and Shiota K. 2004. Biological activities of tethered equine chorionic gonadotropin (eCG) and its deglycosylated mutants. J Reprod Dev. 50:297-304. https://doi.org/10.1262/jrd.50.297
  20. Nakano R, Kitayama S and Yamato M. 1989. Localization of gonadotropin binding sites in human ovarian neoplasms. Am J Obstet Gynecol. 161:905. https://doi.org/10.1016/0002-9378(89)90749-7
  21. Simoni M, Gromoll J and Nieschlag E. 1997. The follicle-stimulating hormone receptor: biochemistry, molecular biology, physiology, and pathophysiology. Endocrine Reviews. 18:739-771. https://doi.org/10.1210/edrv.18.6.0320
  22. Simoni M and Nieschlag E. 1995. FSH in therapy: physiological basis, new preparations and clinical use. Reprod Med Rev. 4:163-177. https://doi.org/10.1017/S0962279900001150
  23. Stouffer RL, Grodin MS, Davis JR and Surwit EA. 1984. Investigation of binding sites for follicle-stimulating hormone and chorionic gonadotropin in human ovarian cnacers. J Clin Endocrinol Metab. 59:441-446. https://doi.org/10.1210/jcem-59-3-441
  24. Tapanainen JS, Aittomaki K, Min J, Vaskivuo T and Huhtaniemi IT. 1997. Men homozygous for an inactivating mutations of the follicle-stimulating hormone receptor gene present variable suppression of spermatogenesis and fertility. Nat Genet. 15:205-206. https://doi.org/10.1038/ng0297-205